• Users Online: 208
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2022| January-March  | Volume 5 | Issue 1  
    Online since March 31, 2022

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL ARTICLES
Outcome of COVID-19 on Indian patients with cancer: A multicenter, retrospective study
Arun Seshachalam, SV Saju, Honey Susan Raju, Krishnakumar Rathnam, Murugesan Janarthinakani, Krishna Prasad, Channappa Patil, Parameswaran Anoop, Neelesh Reddy, Satish Kumar Anumula, Krishna Reddy Golamari, Sravan Kumar Bodepudi, Madhav Danthala, Basawantrao Malipatil, G Senthilkumar, Kesavan Niraimathi, SG Raman
January-March 2022, 5(1):11-18
DOI:10.4103/crst.crst_212_21  
  486 58 -
MUSINGS
Impact of COVID-19 on global waste and the need for mitigation
Nivedita Chakrabarty, Shreya Shukla, Abhishek Mahajan
January-March 2022, 5(1):7-10
DOI:10.4103/crst.crst_67_22  
  460 40 -
ORIGINAL ARTICLES
Preference and Satisfaction with Cancer Institute quality of life questionnaire, (CI - QoL) V. II and EORTC QLQ-C30 Tamil version: An observational study
Sasikala Athikesavan, Vidhubala Elangovan, Sundaramoorthy Chidambaram, Surendran Veeraiah
January-March 2022, 5(1):26-34
DOI:10.4103/crst.crst_218_21  
  452 35 -
ORIGINAL ARTICLE: GERIATRIC ONCOLOGY SECTION
Timed Up and Go as a predictor of mortality in older Indian patients with cancer: An observational study
Abhijith Rajaram Rao, Sharath Kumar, Ratan Dhekale, Jyoti Krishnamurthy, Sarika Mahajan, Anuradha Daptardar, Anant Ramaswamy, Vanita Noronha, Vikram Gota, Shripad Banavali, Kumar Prabhash
January-March 2022, 5(1):75-82
DOI:10.4103/crst.crst_79_22  
  446 33 -
ORIGINAL ARTICLES
Deep learning-based COVID-19 triage tool: An observational study on an X-ray dataset
Abhishek Mahajan, Vivek Pawar, Vivek Punia, Aakash Vaswani, Piyush Gupta, KS S. Bharadwaj, Arvind Salunke, Sujit D Palande, Kalashree Banderkar, M L V. Apparao
January-March 2022, 5(1):19-25
DOI:10.4103/crst.crst_162_21  
  394 61 -
Significance of too-small-to-characterize (TSTC) pulmonary nodules in known extrapulmonary solid tumors: A retrospective observational study
Abhishek Mahajan, Matthew Monachen, Shreya Shukla, Ujjwal Agarwal, Nilesh Sable, Kumar Prabhash, Swapnil Rane, Meenakshi Thakur
January-March 2022, 5(1):59-66
DOI:10.4103/crst.crst_228_21  
  408 42 -
PATIENT/CAREGIVER CORNER
You can (cer) do it!
Ananya Pendekanti
January-March 2022, 5(1):85-87
DOI:10.4103/crst.crst_321_21  
  268 159 -
REVIEW ARTICLE
Body image disturbances among breast cancer survivors: A narrative review of prevalence and correlates
Monika Thakur, Roopali Sharma, Anand Kumar Mishra, Bandna Gupta
January-March 2022, 5(1):90-96
DOI:10.4103/crst.crst_170_21  
  348 45 -
ORIGINAL ARTICLES
Diagnostic accuracy of mammography in characterizing breast masses using the 5th edition of BI-RADS: A retrospective study
Suvendu Kumar Mohapatra, Prafulla Kumar Das, Rashmita Binod Nayak, Abhisek Mishra, Bhagyalaxmi Nayak
January-March 2022, 5(1):52-58
DOI:10.4103/crst.crst_224_21  
  340 44 -
RESIDENT CORNER
My experience with medical oncology fellowship training at the Tata Memorial Hospital
Mahamat Saleh Baldass
January-March 2022, 5(1):111-112
DOI:10.4103/crst.crst_77_21  
  348 30 -
MUSINGS
Optimizing the bed distribution system in resource-constrained settings
Bal Krishna Mishra, Akhil Kapoor
January-March 2022, 5(1):5-6
DOI:10.4103/crst.crst_81_22  
  328 47 -
From Diamond Princess to Cordelia Cruises (Empress): Déjà vu in the New Year, lessons unlearned!
Nivedita Chakrabarty, Abhishek Mahajan
January-March 2022, 5(1):1-4
DOI:10.4103/crst.crst_20_22  
  327 46 -
ORIGINAL ARTICLES
Impact of demographic factors on delayed presentation of oral cancers: A questionnaire-based cross-sectional study from a rural cancer center
Anshul Singla, Alok K Goel, Simmi Oberoi, Shivani Jain, Deepak Singh, Rakesh Kapoor
January-March 2022, 5(1):45-51
DOI:10.4103/crst.crst_318_21  
  286 41 -
LETTERS TO EDITOR
M. masseter pars coronoidea: Gateway between the masticator space and infratemporal fossa
Abhishek Mahajan, Vasundhara Smriti
January-March 2022, 5(1):185-186
DOI:10.4103/crst.crst_9_22  
  290 23 -
MOLECULAR TUMOR BOARD
EGFR exon 20 insertion in non-small cell lung cancer
Goutam Santosh Panda, Vanita Noronha, Omshree Shetty, Subhash Yadav, Rajiv Kumar, Vijay Patil, Pratik Chandrani, Amit Janu, Abhishek Mahajan, Anuradha Chougule, Kumar Prabhash
January-March 2022, 5(1):122-130
DOI:10.4103/crst.crst_77_22  
  270 43 -
PATIENT/CAREGIVER CORNER
Caregiving: A journey unacknowledged
Vandana Mahajan
January-March 2022, 5(1):88-89
DOI:10.4103/crst.crst_29_22  
  150 140 -
REVIEW ARTICLE-BIOMARKER SERIES
A narrative review of ERBB2 in non-small cell lung carcinoma
Mansi Sharma, Abhinav Dewan, Himanshi Diwan, Shrinidhi Nathany, Ullas Batra
January-March 2022, 5(1):97-104
DOI:10.4103/crst.crst_323_21  
  258 26 -
LETTERS TO EDITOR
Future scope of virtual reality and augmented reality in tobacco control
Harsh Priya, Bharathi M Purohit, Priyanka Ravi
January-March 2022, 5(1):173-174
DOI:10.4103/crst.crst_22_22  
  220 57 -
DRUG REVIEW
Romiplostim – A narrative drug review
Anuj Gupta, Akhil Kapoor, Amit Choudhary, Sujeet Kumar, Bal Krishna Mishra
January-March 2022, 5(1):105-110
DOI:10.4103/crst.crst_17_22  
  228 20 -
ORIGINAL ARTICLE - REAL WORLD DATA
Clinicopathologic features and outcomes of diffuse large B-cell lymphoma with extranodal involvement: A retrospective analysis
Sukesh C Nair, Ajay Gogia, Shalabh Arora, Lalit Kumar, Atul Sharma, Ahitagni Biswas, Ritu Gupta, Saumyaranjan Mallick
January-March 2022, 5(1):67-74
DOI:10.4103/crst.crst_204_21  
  214 34 -
ORIGINAL ARTICLES
Construction and validation of palliative care nursing theory guidelines for patients with advanced cancer
C Vasantha Kalyani, Kusum K Rohilla, Amit Gupta, Sweety Gupta, Manoj Gupta, Nirmal Matella
January-March 2022, 5(1):35-44
DOI:10.4103/crst.crst_307_21  
  218 22 -
LETTERS TO EDITOR
P values need to be correctly understood and read along with 95% confidence intervals
Chittaranjan Andrade
January-March 2022, 5(1):147-148
DOI:10.4103/crst.crst_54_22  
  210 22 -
STATISTICAL RESOURCE
Are you confident about your confidence in confidence intervals?
HS Darling
January-March 2022, 5(1):139-144
DOI:10.4103/crst.crst_75_22  
  190 32 -
LETTERS TO EDITOR
Relatlimab and nivolumab in untreated advanced melanoma
Shuvadeep Ganguly, Ajay Gogia
January-March 2022, 5(1):196-197
DOI:10.4103/crst.crst_71_22  
  186 19 -
Immunotherapy for triple-negative breast cancer: Time to pause?
Vamshi Krishna Muddu, Nanditha Boindala
January-March 2022, 5(1):182-183
DOI:10.4103/crst.crst_42_22  
  184 18 -
Adjuvant pembrolizumab in renal cell carcinoma
Raghav Raodha, Ajay Gogia, Annie Baa
January-March 2022, 5(1):191-191
DOI:10.4103/crst.crst_10_22  
  180 10 -
IMAGE CHALLENGES
Diagnostic quandary over a cheek(y) neoplasm
Shreya Shukla, Ujjwal Agarwal, Vasundhara Patil, Swapnil Rane, Nandini Menon, Vanita Noronha, Vijay Patil, Kumar Prabhash, Abhishek Mahajan
January-March 2022, 5(1):131-135
DOI:10.4103/crst.crst_274_21  
  164 21 -
LETTERS TO EDITOR
Improving access to technology among older adults with cancer: Current perspectives and future priorities
Andrea de-la-O-Murillo, Enrique Soto-Perez-de-Celis
January-March 2022, 5(1):162-163
DOI:10.4103/crst.crst_33_22  
  170 13 -
Is cabozantinib the common answer to all radioiodine-refractory differentiated thyroid cancers?
Akhil Kapoor, Vijay M Patil, Kumar Prabhash
January-March 2022, 5(1):194-195
DOI:10.4103/crst.crst_15_22  
  164 18 -
Lenvatinib: With more power comes more toxicity
Shikhar Kumar
January-March 2022, 5(1):177-178
DOI:10.4103/crst.crst_18_22  
  114 65 -
Is there a place today for augmented and virtual reality in cigarette smoking cessation?
Pankaj Chaturvedi, Arjun Singh
January-March 2022, 5(1):172-173
DOI:10.4103/crst.crst_12_22  
  152 19 -
Authors' reply to Agarwal et al. and Iyer
Ajeet Kumar Gandhi, Ajay Gogia
January-March 2022, 5(1):152-153
DOI:10.4103/crst.crst_61_22  
  152 15 -
Making the seniors tech savvy: The way forward to bringing cancer care to the doorstep
Naganath Narasimhan Prem, Anupa Pillai, Joyita Banerjee
January-March 2022, 5(1):163-164
DOI:10.4103/crst.crst_43_22  
  150 15 -
Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer
Shuvadeep Ganguly, Ajay Gogia
January-March 2022, 5(1):195-196
DOI:10.4103/crst.crst_84_22  
  148 14 -
Profile and outcome of advanced malignant melanoma in India: Need for cost-effective innovations
Shuvadeep Ganguly, Sameer Bakhshi
January-March 2022, 5(1):157-158
DOI:10.4103/crst.crst_30_22  
  140 17 -
Authors' reply to Chaudhary et al. and Soni et al.
Avaronnan Manuprasad, Vineetha Raghavan, Praveen K Shenoy, Aswathi Krishnan, Chandran K Nair
January-March 2022, 5(1):156-157
DOI:10.4103/crst.crst_76_22  
  138 17 -
Malignant melanoma in India: Is it time to set the wheels in motion?
Bivas Biswas, Somnath Roy, Sandip Ganguly
January-March 2022, 5(1):159-160
DOI:10.4103/crst.crst_37_22  
  138 15 -
Authors' reply to Arun, Biswas et al., and Ganguly et al.
Sameer Rastogi, Sorun Shishak, Abhenil Mittal
January-March 2022, 5(1):161-162
DOI:10.4103/crst.crst_91_22  
  136 15 -
EDITORIALS
Perceptions and realities about early mortality rates from COVID-19 in Indian patients with cancer
Vinayak V Maka, Santhosh K Devadas
January-March 2022, 5(1):113-116
DOI:10.4103/crst.crst_90_22  
  136 13 -
LETTERS TO EDITOR
Authors' reply to Sreeram and Subramaniam
Abhishek Mahajan, Richa Vaish, Shreya Shukla, Ujjwa Agarwal
January-March 2022, 5(1):181-182
DOI:10.4103/crst.crst_83_22  
  126 21 -
IMAGE CHALLENGES
What's that in the infratemporal fossa?
Abhishek Mahajan, Renuka Ashtekar, Ujjwal Agarwal, Shreya Shukla
January-March 2022, 5(1):136-138
DOI:10.4103/crst.crst_251_21  
  126 20 -
EDITORIALS
Use of artificial intelligence on chest skiagrams in patients with COVID-19: Time to widen the horizon
Atul Kapoor
January-March 2022, 5(1):116-118
DOI:10.4103/crst.crst_39_22  
  125 20 -
LETTERS TO EDITOR
Problems associated with inadequate surgery in patients with cervical cancer: Can they be avoided?
Mrinalini Verma, Kirti Srivastava, Sanjay Singhal, M L B Bhatt
January-March 2022, 5(1):145-147
DOI:10.4103/crst.crst_52_22  
  132 12 -
EDITORIALS
Extranodal diffuse large B-cell lymphoma: Real-world experience from an Indian tertiary cancer center
MC Suresh Babu, A Sreevalli
January-March 2022, 5(1):119-121
DOI:10.4103/crst.crst_93_22  
  120 23 -
LETTERS TO EDITOR
Is CROSS the right approach for locally advanced esophageal cancer in India?
HN Arun
January-March 2022, 5(1):165-166
DOI:10.4103/crst.crst_47_22  
  132 10 -
Indian real-world data on melanoma
HN Arun
January-March 2022, 5(1):158-159
DOI:10.4103/crst.crst_40_22  
  128 13 -
Authors' reply to Bhattacharyya et al., Thammineedi et al., and Arun
Tapas Kumar Dora, Tushar Aeron, Abhishek Chatterjee, Jayashree Deshmukh
January-March 2022, 5(1):169-171
DOI:10.4103/crst.crst_65_22  
  118 23 -
Are we there RET?
Ashutosh Jaiswal, Raajit Chanana
January-March 2022, 5(1):175-176
DOI:10.4103/crst.crst_28_22  
  122 16 -
Pathological complete response in locally advanced breast cancer after neoadjuvant chemotherapy: Hope or hype
Reshu Agarwal, Vijaykumar Dehannathparambil Kottarathil
January-March 2022, 5(1):150-151
DOI:10.4103/crst.crst_24_22  
  118 19 -
Day 14 bone marrow response assessment in acute myeloid leukemia: Should we discontinue?
Shilpi Chaudhary, Shuvadeep Ganguly, Sameer Bakhshi
January-March 2022, 5(1):153-154
DOI:10.4103/crst.crst_44_22  
  122 15 -
iT may improve prognostication but is not meant for staging in its current form
MP Sreeram, Narayana Subramaniam
January-March 2022, 5(1):179-180
DOI:10.4103/crst.crst_34_22  
  122 14 -
Neoadjuvant chemoradiation followed by surgery in operable carcinoma esophagus: Is the real-world scenario too far from clinical trial settings?
Tapesh Bhattacharyya, Indranil Mallick, Moses Arun Singh
January-March 2022, 5(1):166-167
DOI:10.4103/crst.crst_48_22  
  124 11 -
Does the radiation dose in neoadjuvant chemoradiation in resectable esophageal carcinoma matter in the Indian scenario?
Subramanyeshwar Rao Thammineedi, Sujith Chyau Patnaik, Syed Nusrath
January-March 2022, 5(1):167-169
DOI:10.4103/crst.crst_58_22  
  122 9 -
Lenvatinib: A potent oral tyrosine kinase inhibitor across multiple histologies with differing dosages
Bipinesh Sansar, Neha Singh, Arpita Singh
January-March 2022, 5(1):178-179
DOI:10.4103/crst.crst_31_22  
  112 17 -
Authors' reply to Singh and Chaturvedi, and Priya et al.
S Canty Sandra, Anusha Raghavan, PD Madan Kumar
January-March 2022, 5(1):174-175
DOI:10.4103/crst.crst_50_22  
  114 14 -
Authors' reply to de-la-O-Murillo and Soto-Perez-de-Celis, and Prem et al.
Abhijith Rajaram Rao, Vanita Noronha, Anant Ramaswamy, Kumar Prabhash
January-March 2022, 5(1):164-165
DOI:10.4103/crst.crst_63_22  
  110 18 -
The day 14 conundrum still remains unresolved!
Priyanka Soni, Naveen Gupta, Hemant Malhotra
January-March 2022, 5(1):155-156
DOI:10.4103/crst.crst_49_22  
  110 17 -
Authors' reply to Jaiswal and Chanana
Ullas Batra, Shrinidhi Nathany, Himanshi Diwan
January-March 2022, 5(1):176-177
DOI:10.4103/crst.crst_62_22  
  116 9 -
Author's reply to Andrade
HS Darling
January-March 2022, 5(1):148-149
DOI:10.4103/crst.crst_87_22  
  110 14 -
Authors' reply to Muddu and Boindala
Rakesh Sharma, Ajay Gogia
January-March 2022, 5(1):183-184
DOI:10.4103/crst.crst_66_22  
  112 10 -
Vemurafenib plus rituximab in relapsed or refractory hairy cell leukemia
Annie Kanchan Baa, Ajay Gogia
January-March 2022, 5(1):188-188
DOI:10.4103/crst.crst_8_22  
  112 10 -
POETRY IN ONCOLOGY
The emancipation
Nivedita Chakrabarty
January-March 2022, 5(1):83-83
DOI:10.4103/crst.crst_3_22  
  106 16 -
LETTERS TO EDITOR
Transplantation and maintenance in multiple myeloma appear to overcome differences in induction regimens
Jagdeep Singh, Kaveri Joshi, Suvir Singh
January-March 2022, 5(1):186-188
DOI:10.4103/crst.crst_291_21  
  106 14 -
POETRY IN ONCOLOGY
Superhero
Archi Rungta
January-March 2022, 5(1):84-84
DOI:10.4103/crst.crst_16_22  
  106 12 -
LETTERS TO EDITOR
Preparation is key: Prehabilitation for patients receiving high-dose chemotherapy and autologous stem cell transplant
Suvir Singh, Gurkirat Kaur
January-March 2022, 5(1):193-194
DOI:10.4103/crst.crst_35_22  
  110 7 -
Secondary cytoreductive surgery in recurrent ovarian carcinoma
Shuvadeep Ganguly, Ajay Gogia
January-March 2022, 5(1):192-193
DOI:10.4103/crst.crst_14_22  
  108 8 -
Microbiota as a predictor of mortality in allogeneic hematopoietic cell transplantation
Rakesh Sharma, Ajay Gogia, Annie Kanchan Baa
January-March 2022, 5(1):191-192
DOI:10.4103/crst.crst_11_22  
  102 8 -
Changing the paradigm of treatment in locally advanced breast cancers: Can we impact outcomes in resource-limited settings by improving pathological complete response?
Priya Iyer
January-March 2022, 5(1):149-150
DOI:10.4103/crst.crst_32_22  
  92 11 -
Organizational aspects of critical care in patients with hematologic malignancies and those undergoing stem cell transplantation
Suvir Singh, Vivek K Gupta, Gurkirat Kaur
January-March 2022, 5(1):189-190
DOI:10.4103/crst.crst_5_22  
  86 13 -